These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 749523)

  • 1. [Denegyt (R) metabolism in rats and dogs].
    Jerkovich G; Elekes I; Lázaŕ-Magyar A; Horváth G
    Acta Pharm Hung; 1978; 48 Suppl():26-9. PubMed ID: 749523
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism, disposition, and pharmacokinetics of a potent anticonvulsant, 4-amino-N-(2,6-dimethylphenyl)benzamide (LY201116), in rats.
    Potts BD; Gabriel S; Parli CJ
    Drug Metab Dispos; 1989; 17(6):656-61. PubMed ID: 2575503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of novel trans-4-(substituted-benzamido)-3,4-dihydro-2H-benzo[b]-pyran-3-ol derivatives as potential anticonvulsant agents with a distinctive binding profile.
    Chan WN; Evans JM; Hadley MS; Herdon HJ; Jerman JC; Morgan HK; Stean TO; Thompson M; Upton N; Vong AK
    J Med Chem; 1996 Nov; 39(23):4537-9. PubMed ID: 8917640
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biotransformation and pharmacokinetics of mesoionic didehydro-4-methyl-5-phenyl-1,3,4-thiadiazolidine-2-thione (LU 2443). Studies on its biotransformation in rats].
    Neidlein R; Eder T
    Arzneimittelforschung; 1982; 32(10):1292-8. PubMed ID: 6891230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetic and metabolic aspects of parsalmide in various animal species and man].
    Fleischmann L
    Boll Chim Farm; 1980 Jul; 119(7):385-90. PubMed ID: 6893933
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of the binding of [3H]-SB-204269, a radiolabelled form of the new anticonvulsant SB-204269, to a novel binding site in rat brain membranes.
    Herdon HJ; Jerman JC; Stean TO; Middlemiss DN; Chan WN; Vong AK; Evans JM; Thompson M; Upton N
    Br J Pharmacol; 1997 Aug; 121(8):1687-91. PubMed ID: 9283704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and disposition of (R)-4-[3-(2-hydroxy-2-phenyl)ethylamino-3-methylbutyl]benzamide Hcl (LY 195448) in rodents.
    Ho DH; Covington WP; Lin J; Brown NS; Newman RA
    Res Commun Chem Pathol Pharmacol; 1989 Nov; 66(2):255-67. PubMed ID: 2602657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition and metabolism of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine in rats, dogs, and monkeys.
    Hucker HB; Hutt JE; White SD; Arison BH; Zacchei AG
    Drug Metab Dispos; 1983; 11(1):54-8. PubMed ID: 6132797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the metabolism of MY 41-6 in the dog].
    Fleischmann L; Gradnik B
    Arzneimittelforschung; 1973 Oct; 23(10):1457-60. PubMed ID: 4801329
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid in vivo metabolism of a methylether derivative of (+/-)-BW373U86: the metabolic fate of [3H]SNC121 in rats.
    Schetz JA; Calderon SN; Bertha CM; Rice K; Porreca F
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1069-76. PubMed ID: 8968326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous biotransformation of N-(4-bromobenzoyl)-S,S-dimethyliminosulfurane and its product, 4-bromobenzamide, leading to percutaneous penetration enhancement of drugs: initial evidence using hydrocortisone.
    Sintov AC; Zhang PJ; Michniak-Kohn BB
    J Control Release; 2009 Jan; 133(1):44-51. PubMed ID: 18950667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
    Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W
    Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-pass metabolism of gentisamide: influence of intestinal metabolism on hepatic formation of conjugates. Studies in the once-through vascularly perfused rat intestine-liver preparation.
    Hirayama H; Pang KS
    Drug Metab Dispos; 1990; 18(5):580-7. PubMed ID: 1981705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotransformation of tolterodine, a new muscarinic receptor antagonist, in mice, rats, and dogs.
    Andersson SH; Lindgren A; Postlind H
    Drug Metab Dispos; 1998 Jun; 26(6):528-35. PubMed ID: 9616187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of the anticonvulsant agent zonisamide in the rat.
    Stiff DD; Zemaitis MA
    Drug Metab Dispos; 1990; 18(6):888-94. PubMed ID: 1981533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo metabolism of clebopride in three animal species and in man.
    Segura J; Bakke OM; Huizing G; Beckett AH
    Drug Metab Dispos; 1980; 8(2):87-92. PubMed ID: 6103794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the metabolism of MY 41-6 in the rat].
    Fleischmann L; Gradnik B
    Arzneimittelforschung; 1973 Oct; 23(10):1455-7. PubMed ID: 4801328
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on metabolism of 6-chloro butyl phthalide by rat liver microsomes].
    Peng SH; Cui YY; Zhou TH
    Yao Xue Xue Bao; 1996; 31(6):466-71. PubMed ID: 9275725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rational conception, synthesis and evaluation of phenytoinergic potential anticonvulsants. A series ofretrobenzamides: N-(nitrophenyl) benzamides and N-(aminophenyl) benzamides].
    Bourhim M; Kanyonyo MD; Lambert DM; Poupaert JH; Stables JP; Vamecq J
    J Pharm Belg; 1997; 52(5):181-9. PubMed ID: 9432526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.